NCT06887023View on ClinicalTrials.gov

Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

February 1, 2025

Conditions
Bile Duct Neoplasms Malignant
Trial Locations (1)

130000

the First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER

NCT06887023 - Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB | Biotech Hunter | Biotech Hunter